"10.1371_journal.pone.0084259","plos one","2014-01-09T00:00:00Z","Daniel Harari; Renne Abramovich; Alla Zozulya; Paul Smith; Sandrine Pouly; Mario Köster; Hansjörg Hauser; Gideon Schreiber","Department of Biological Chemistry, The Weizmann Institute of Science, Rehovot, Israel; MS Platform, Merck-Serono, (a division of Merck KGaA), Geneva, Switzerland; Helmholtz Centre for Infection Research, Dept. Gene Regulation and Differentiation, Braunschweig, Germany","Conceived and designed the experiments: DH SP GS. Performed the experiments: DH RA. Analyzed the data: DH GS. Contributed reagents/materials/analysis tools: MK HH. Wrote the paper: DH AZ PS SP GS.","A number of the authors of this manuscript are/were employed by Merck-Serono. Research performed was funded by Merck-KGaA (the parental company of Merck-Serono). Additionally, the authors declare that the disclosed patented technologies relating to IFN superagonists are associated with patent filings: USA: 60/694,810 and PCT/IL2006/000754 (along with downstream national filings). The authors will openly share their reagents described in this paper with academic institutions. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Daniel Harari","DH",8,TRUE,3,2,2,5,TRUE,TRUE,FALSE,0,NA,FALSE
